Hereditary nonpolyposis colorectal cancer (HNPCC) is commonly associated with at least three currently known DNA mismatch repair genes: (a) hMSH2; (b) hMLH1; and (c) hMSH6. A majority of HNPCC families has identifiable mutations in hMLH1 and hMSH2. When these mutations cause an inherited risk of colorectal cancer, they are also most often associated with microsatellite instability in the tumors. Recently, hMLH3 was suggested to be causative in HNPCC. We screened 70 index patients suggestive of a genetic predisposition for germ-line mutations in hMLH3 with denaturing high-performance liquid chromatography. One frameshift mutation and 11 missense mutations were identified in 16 index patients (23%). Most families presented evidence against hMLH3 as a high risk factor in familial colorectal cancer, and most of the mutations were found in the low risk patients, suggesting hMLH3 to be a low risk gene for colorectal cancer. We demonstrate in one family that a hMLH3 mutation segregated with disease together with a missense mutation in hMSH2, which makes us hypothesize that these mutations work together in an additive manner and result in an elevated risk of colorectal tumors in the family. None of the tumors with hMLH3 mutations showed microsatellite instability, which demonstrates that hMLH3 does not make its contribution to carcinogenesis through an impaired DNA mismatch repair function.
Cancer research. 2003 Apr 15;63(8):1894-9. Q116.62025
The role of hMLH3 in familial colorectal cancer
hMLH3在家族性结直肠癌中的作用 翻译改进
作者单位 +展开
作者单位
PMID: 12702580
摘要 Ai翻译
Keywords:hMLH3; colorectal cancer; colorectal cancer
相关内容
-
Infrequent frameshift mutations in the simple repeat sequences of hMLH3 in hereditary nonpolyposis colorectal cancers
遗传性非息肉病性大肠癌中hMLH3简单重复序列罕见的移框突变
Japanese journal of clinical oncology. 2001 Feb;31(2):61-4.
-
A community-based hospital experience with colorectal cancer
社区医院结直肠癌诊疗经验
The Australian and New Zealand journal of surgery. 1997 Jul;67(7):420-3.
-
[Colorectal cancer screening: facts and questions]
结直肠癌筛查:事实与疑问
Gastroenterologie clinique et biologique. 2002 May;26(5 Suppl):B86-93.
-
Interval colorectal cancer: a challenging field in colorectal cancer
结肠癌复发:结直肠癌领域的挑战
Future oncology (London, England). 2018 Jun;14(13):1307-1316.
-
Clinical and Biological Features of Interval Colorectal Cancer
期发结直肠癌的临床和生物学特征分析
Clinical endoscopy. 2017 May;50(3):254-260.
-
Commentary: aspirin and colorectal cancer an epidemiological success story
评论:一项关于阿司匹林与结直肠癌的流行病学研究取得成功
International journal of epidemiology. 2007 Oct;36(5):962-5.
-
Modified enhanced recovery after surgery (ERAS) protocols for patients with obstructive colorectal cancer
改良的加速术后恢复(ERAS)方案在阻塞性结直肠癌患者中的应用
BMC surgery. 2017 Feb 16;17(1):18.
-
Report on the Belgian consensus meeting on colorectal cancer screening
比利时结直肠癌筛查共识会议报告
Acta gastro-enterologica Belgica. 2005 Apr-Jun;68(2):239-40.